Aims b-adrenergic stimulation has profound influence in the genesis and maintenance of atrial fibrillation (AF). However, the effects of b-Adrenoceptor stimulation on repolarizing currents and action potential (AP) characteristics in human atrial myocytes from left (LAA) and right atrial appendages (RAA) obtained from sinus rhythm (SR) and chronic atrial fibrillation (CAF) patients have not been compared yet.
Introduction
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and contributes to population morbidity and mortality.
1,2 Presently available therapeutic approaches have major limitations, 1, 2 therefore, an improved understanding of the mechanistic insights of the disease is needed for the development of novel therapeutic approaches.
Acute and chronic atrial fibrillation (CAF) are characterized by shortening of the action potential (AP) duration (APD) and atrial refractory period (ARP), increased ARP dispersion, and loss of APD adaptation to changes in frequency. 1, 2 Such alterations in atrial electrical properties (electrical remodelling) are caused by derangements in ion channel expression. 1 -3 Importantly, it has been demonstrated that AF-induced electrical remodelling promotes AF maintenance (AF begets AF). 1 -3 Indeed, the shorter the ARP the faster and † These authors are contributed equally.
more stable the re-entry of electrical impulses that sustain the arrhythmia. Among changes of atrial ion channels there are some that do not apparently contribute to the shortening of the ARP, for instance, the expression decrease in the channels generating the ultrarapid component of the delayed rectifier current (I Kur ), and the Ca 2+ -independent 4-aminopyridine (4-AP)-sensitive component of the transient outward current (I to1 ) . 3, 4 Conversely, there are other changes that seem to critically contribute to the abbreviation of APD and ARP. Such is the case of the expression decrease in the channels that generate the depolarizing L-type Ca 2+ current (I CaL ). 5 Moreover, CAF increases the expression of channels that underlie the repolarizing inward rectifier (I K1 ) and the constitutively active acetylcholine-dependent (I KACh ) currents. 6, 7 In the same line, we recently demonstrated that the slow component of the delayed rectifier current (I Ks ) is markedly increased in both left (LA) and right (RA) atrial myocytes from CAF patients. 8 Since I Ks contributes to AP final phase repolarization more at fast than at slow rates, 9 we proposed that I Ks increase would also critically contribute to the abbreviation of APD and ARP, and, thus, to AF maintenance and recurrence. Several data suggest that adrenergic stimulation may be involved in the initiation and/or maintenance of AF. 10 However, it is unclear how adrenergic stimulation affects the various electrophysiological mechanisms that could underlie AF. Previous data demonstrated that CAF is associated with an enhanced effect of isoproterenol to increase I CaL . 5 Conversely, data on the effects of b-adrenergic stimulation on K + repolarizing currents and atrial AP characteristics in patients with CAF are currently unavailable. Thus, in this work we analysed the effects of b-Adrenoceptor stimulation on I to1 , I Kur , I Ks , and I K1 recorded in myocytes obtained from left (LAA) and right (RAA) atrial appendages from sinus rhythm (SR) and CAF patients. We also analysed the effects of isoproterenol on the characteristics of the APs recorded in SR and CAF myocytes. The results demonstrated that CAF markedly enhanced b-Adrenoceptor-mediated effects by increasing the expression of b1-Adrenoceptors. As a consequence of AF-induced changes in channels and receptors stimulation of b-Adrenoceptors in CAF myocytes significantly shortened the APD, an effect that could contribute to the perpetuation of the arrhythmia.
Methods
The study was approved by the Investigation Committee of the Hospital Universitario Gregorio Marañó n (CNIC-13) and conformed to the principles outlined in the Declaration of Helsinki. Each patient gave written informed consent.
Electrophysiological analysis

Human atrial myocyte isolation
Myocytes were enzymatically isolated from RAA and LAA samples, obtained from 36 patients in SR and 32 patients with CAF that underwent cardiac surgery, following methods previously described. 8 Clinical data of patients are summarized in Supplementary material online, Table S1 .
Recording of ionic currents
Currents were recorded at room temperature using the whole-cell patchclamp configuration (micropipette resistance ,3.5 MV). Series resistance was compensated manually and usually ≥80% compensation was achieved. Under our experimental conditions no significant voltage errors (,5 mV) due to series resistance were expected with the micropipettes used. Currents were filtered at half the sampling frequency.
Pulse protocols
The protocol to record I to1 and I sus consisted of 250 ms pulses from 280 mV to potentials ranging 290 and +50 mV. 8 A 25 ms prepulse to 240 mV was applied to inactivate the inward Na + current (I Na ). I Ks was recorded by applying 4 s pulses from 240 mV to potentials ranging 240 and +60 mV and tail currents were elicited upon repolarization to 230 mV in cells previously superfused with 2 mM 4-AP. 8 I K1 was recorded by applying 250 ms pulses from 2120 to +20 mV or by applying 50 ms pulses from 280 mV to 2100 mV followed by depolarizing ramps to +20 mV (800 ms). 8 Finally, I Ca,L was recorded by applying 500 ms pulses that were imposed in 5 mV increments between 240 and +50 mV from a holding potential of 280 mV. I Na was inactivated by the application of a 50 ms prepulse to 230 mV.
Recording of action potentials
APs were recorded at room temperature using the current clamp configuration. 11 Tip resistance of the micropipettes used was .7 MV to ensure high quality gigaseals and minimal depolarization of membrane potential. APs were elicited by 2 ms depolarizing current pulses at 1.5 times the current threshold at a frequency of 1 Hz.
Mathematical model of a human atrial action potential
Effects of isoproterenol on SR human atrial APs driven at 1 Hz were simulated using the mathematical model of 'type 3' AP developed by Courtemanche et al. 12 by incorporating the experimentally measured isoproterenol effects on I to1 , I Ks , and I CaL (Supplementary material online). CAF-remodelled type 3 APs were obtained considering a 70% reduction in I CaL , a 50% reduction in I to1 and I Kur , 12 and a 100% increase in I K1 and I Ks . Finally, we also modelled CAF APs without considering the I Ks increase.
Drugs
Drugs were dissolved as appropriate to yield 0.01 M stock solutions. Stock solutions of isoproterenol were prepared fresh daily in deionized water containing 0.04% ascorbic acid.
Analysis of the mRNA expression
Total RNA was isolated from human atrial appendages obtained from 5 SR and CAF patients, respectively (Supplementary material online, Table  S2 ), 8, 11 and real-time quantitative PCR (qPCR) using Taqman-based ABI gene expression assays was performed. The cycle to threshold (Ct) values corresponding to mRNA levels were normalized to 18S rRNA. To compare expression differences, the respective data were transformed from DCt values to equivalent fold differences as described in the Supplementary material online.
Statistical methods
Results are expressed as mean + SEM. An unpaired t-test or one-way ANOVA followed by the Newman-Keuls test were used to assess statistical significance. Comparisons between categorical variables were done using Fisher's exact test. A value of P , 0.05 was considered significant. A multiple linear regression was used to identify putative associations between isoproterenol-induced effects and some clinical characteristics or pharmacological treatments of the patients. To make comparisons between two different concentration-response curves, an F-test was used. All experimental procedures are exhaustively described in the Supplementary material online.
Results
For electrophysiological experiments, we analysed 36 and 32 samples obtained from SR and CAF patients (Supplementary material online, Figure  S1B ). I to1 -predominant cells accounted for 30% of the cells and exhibited an outward current mainly composed of a fast-activating and inactivating I to1 . I to1 was completely absent in 30% of the cells which presented a fast-activating non-inactivating current (I sus predominant). The most abundant cells were those that exhibited both I to1 and sustained currents (intermediate pattern). CAF modified the distribution of these cell types mainly by decreasing the percentage of I to1 -predominant cells in both atria (Supplementary material online, Figure S1C ). Figure 1A and B shows the effects of isoproterenol (1 nM), a b-Adrenoceptor agonist, on currents elicited by 250 ms pulses from 280 mV to potentials ranging from 290 to +50 mV in RAA cells with an intermediate pattern obtained from an SR and a CAF patient. At very positive potentials, an outward current was composed of I to1 and I sus . In both SR and CAF myocytes, isoproterenol decreased peak current amplitude, whereas it did not modify the I sus measured at the end of the test pulses. Supplementary material online, Figure S2 shows I to1 density -voltage relationships for LAA and RAA myocytes from SR and CAF patients in the absence and presence of isoproterenol 1 nM. I to1 was measured, in cells with I to1 -predominant and intermediate patterns, as the difference between the peak and the current at the end of the 250 ms pulse. Our results confirmed that CAF reduced I to1 density in both atria, the effect being significantly more marked in the LAA than in the RAA. 8 As can be observed, in SR and CAF myocytes isoproterenol significantly decreased I to1 density at potentials .+20 mV in both LAA and RAA cells (Supplementary material online, Figure S2 ). We further analysed the isoproterenol-induced decrease in I to1 density at +30 mV, a positive membrane potential easily reached under physiological conditions ( Figure 1C) . In SR cells isoproterenol similarly decreased I to1 density in both atria. Compared with SR, CAF significantly enhanced the isoproterenol-induced I to1 inhibition, an effect that was significantly greater in the LAA than in the RAA (n ¼ 16, P , 0.05). Importantly, isoproterenol effects were prevented in both SR and CAF cells by atenolol (1 mM), a b1-selective adrenoceptor antagonist ( Figure 1D ), suggesting that I to1 inhibition was mediated by b1-Adrenoceptor stimulation.
Effects of isoproterenol on I to1
Since isoproterenol-induced I to1 inhibition has never been reported before, we explored the underlying signalling pathway. The results demonstrated that the isoproterenol I to1 inhibitory effects were abolished in the presence of either 9-cyclopentyladenine, a selective inhibitor of adenylyl cyclase (AC), or by the intracellular dialysis with PKI, a protein kinase A (PKA) inhibitor (Supplementary material online, Figure S3 ). Thus, our preliminary results suggested that the I to1 inhibition was mediated by the canonical signalling pathway of b1-Adrenoceptors.
The concentration that produces the half-maximum effect (EC 50 ), the maximum effect (E max ), and the Hill coefficient (n H ) were calculated by fitting the Hill equation to the I to1 inhibition produced by different isoproterenol concentrations in LAA and RAA cells from SR and CAF patients (Figure 2A and B). Comparison of the EC 50 confirmed that in both atria isoproterenol more potently inhibited I to1 in CAF than in SR cells ( Figure 2C ) the effect being significantly more marked in the LAA than in the RAA. Isoproterenol produced b-Adrenoceptors and human atrial repolarizing currents a voltage-and time-independent I to1 inhibition since it did not modify the midpoint of the inactivation curve or the time constant of I to1 inactivation either in SR or CAF myocytes (Supplementary material online, Figure S4 and Table S3 ).
Effects of isoproterenol on I sus
Supplementary material online, Figure S5 shows the effects of isoproterenol (1 nM) in I sus -predominant RAA cells obtained from an SR and a CAF patient, respectively. Supplementary material online, Figure S6 shows Figure S5D ). Under these conditions, isoproterenol did not modify the I Kur recorded in SR and CAF myocytes.
Effects of isoproterenol on I Ks
4-AP at 2 mM simultaneously blocks I Kur and I to1 .
13 Figure 3A and B
shows the effects of isoproterenol on 2 mM 4-AP-resistant currents elicited in SR and CAF myocytes from the RAA. Supplementary material online, Figure S7 shows I Ks density -voltage relationships obtained in LAA and RAA cells from SR and CAF patients in the presence and absence of isoproterenol. The 4-AP-resistant component amplitude (measured as the difference between the amplitude at the end and the beginning of the pulse) was small in SR cells, its density being similar in RAA and LAA cells (0.2 + 0.03 pA/pF at +30 mV, n ¼ 16) (Supplementary material online, Figure S7 ). Figure S8 and Table S4 ) and a voltage dependence also congruent with those of I Ks (Supplementary material online, Table S4 ). 8 Isoproterenol significantly increased I Ks density at potentials .+20 mV and .220 mV in SR and CAF myocytes, respectively (Supplementary material online, Figure S7 ). Figure 3C analyses the isoproterenol-induced increase in I Ks density at +30 mV in SR and CAF cells. Importantly, in CAF cells I Ks augmentation was significantly more marked than in SR cells and significantly greater in LAA than in RAA cells. Moreover, I Ks augmenting effects produced by isoproterenol were abolished in the presence of atenolol ( Figure 3D) . Figure 2D and E shows the increase in I Ks density at +30 mV as a function of isoproterenol concentration. The results demonstrated that isoproterenol was significantly more potent for increasing I Ks in CAF than in SR cells this effect being more marked in LAA than in RAA cells ( Figure 2F) . In CAF myocytes, effects of isoproterenol on I Ks were voltage-and time-dependent, since they were accompanied by a leftward shift of the midpoint of the activation curve and an acceleration of the activation kinetics (Supplementary material online, Figure 4A shows I K1 traces recorded by applying voltage-ramps in an LAA myocyte from a CAF patient in the absence and presence of isoproterenol. Inward rectifier currents were recorded in the presence of glibenclamide (10 mM) and atropine (1 mM) and were inhibited by BaCl 2 (100 mM), thus suggesting that the current recorded under these conditions was actually I K1 .
Effects of isoproterenol on I K1
11 Figure 4C and D shows the effects of isoproterenol on I K1 density-voltage curves obtained in LAA and RAA cells from SR and CAF patients. I K1 amplitude was measured at the end of 250 ms pulses applied from 280 mV to potentials ranging from 2120 to +20 mV. The results confirmed data previously reported, i.e. I K1 density significantly augments in CAF myocytes 7 and demonstrated that isoproterenol only inhibited I K1 at potentials negative to the K + reversal potential (E K ). The percentage of I K1 block at 2100 mV ( Figure 4B ) and the analysis of the concentration dependence ( Figure 4E and F ) demonstrated that CAF significantly enhanced the isoproterenol inhibitory effects on I K1 in both atria.
b1-Adrenoceptor remodelling
We next investigated the expression level of AC V (ACV) and VI (ACVI), phosphodiesterase 3A (PDE3A) and 4D (PDE4D), and b1-Adrenoceptors. Ct values corresponding to b1-Adrenoceptor mRNA levels normalized to 18S rRNA (DCt) were significantly lower in CAF than in SR samples (n ¼ 20) (Figure 5A ). Transformation of DCt to fold differences demonstrated that b1-Adrenoceptor expression was 27% greater in CAF than in SR ( Figure 5B) . Conversely, no significant differences were found in mRNA levels of ACV, ACVI, PDE3A, and PDE4D between CAF and SR samples. Furthermore, the increase in b1-Adrenoceptor expression was greater in the LAA than in the RAA ( Figure 5C ).
Effects of isoproterenol on APD
We analysed the effects of b-Adrenoceptor stimulation on APs recorded in SR and CAF myocytes from the RAA. Figure 6A and B shows examples of APs recorded in RAA cells obtained from an SR and a CAF patient, respectively. Under our experimental conditions a single type of AP was recorded either in SR or CAF cells. However, as is evident in Figure 6 , APs recorded in CAF myocytes were quite different from those recorded in SR cells since they were significantly shorter in duration. 3 This APD shortening reached statistical significance when measured at 50% (APD 50 ) and 90% (APD 90 ) of repolarization ( Figure 6C) Figure 6C and D) . Conversely, in CAF myocytes isoproterenol significantly lengthened the APD 20 and, more importantly, it shortened the APD 90 ( Figure 6C and D) . Thus, these results suggest, for the first time, that b1-Adrenoceptor stimulation could differentially modify APD in SR and CAF myocytes, by promoting, in the latter, the shortening of the APD 90 .
Effects of isoproterenol on I CaL
Since I CaL plays a key role in determining APD, we analysed the effects of isoproterenol on I CaL recorded in RAA SR and CAF myocytes. Our results confirmed previous observations 5 demonstrating that CAF Figure S9A demonstrated that 1 nM isoproterenol slightly but significantly increased I CaL (13.5 + 1.6% at +5 mV, n ¼ 10, P , 0.05), the EC 50 and the E max for this effect being 18.2 + 1.9 nM and 156 + 3.5%, respectively (Supplementary material online, Figure S9C ). CAF significantly enhanced the isoproterenol increasing effects on I CaL , the EC 50 and E max for this effect being 4.8 + 0.7 nM and 300 + 21.3%, respectively (Supplementary material online, Figure S9C ). In fact, 1 nM isoproterenol increased I CaL by 24.1 + 3.1% (at +5 mV, n ¼ 10, P , 0.05 vs. SR) (Supplementary material online, Figure S9B ).
Mathematical model of SR and CAF-remodelled AP
To get further insight on the mechanism responsible for the differential effects of isoproterenol on APD in SR and CAF myocytes, we ran a mathematical model of 'type 3' human atrial AP developed by Courtemanche et al. 12 Among the three types described by the model we selected 'type 3' AP because its triangular shape is almost identical to that of the APs we recorded experimentally ( Figure 6E) . To simulate the effects of 1 nM isoproterenol in RAA SR myocytes, I to1 conductance was reduced by 10.6%, whereas I Ks and I CaL conductance were increased by 30.0, and 13.5%, respectively. The effects of isoproterenol on I K1 were not considered since they only appeared at potentials negative to the E K . Isoproterenol produced an APD prolongation ( Figure 6E) , whose magnitude was similar to that obtained experimentally ( Figure 6D ).
To simulate 'type 3' AP under CAF conditions I CaL , I to1 , and I Kur conductances were decreased by 70, 50, and 50%, respectively, as described by Courtemanche et al. 12 Additionally, we included a 100% increase in I Ks and I K1 to take into consideration CAF-induced modifications that have been described after the model had been published ( Figure 6F ). 7, 8 To simulate the effects of 1 nM isoproterenol in CAF-remodelled AP, I to1 conductance was reduced by 28.7%, whereas I Ks and I CaL conductance were increased by 52.0 and 24.1%, respectively. Moreover, the effects of isoproterenol on the activation kinetics and the voltage-dependence of the activation of I Ks were also considered. Under these conditions, the model reproduced the isoproterenol-induced shortening of APD 90 ( Figure 6F ) which was of similar magnitude to that experimentally obtained ( Figure 6D ). Finally, we simulated CAF-remodelled APs by incorporating the reduction in I CaL, I to1 , and I Kur and the increase in I K1 , while omitting the increase in I Ks (control in Figure 6G ). Under these conditions, isoproterenol did not shorten but lengthened the APD 90 ( Figure 6D and G).
Discussion
The present results demonstrated that CAF upwardly regulated b1-Adrenoceptor expression, this effect being more marked in the LAA than in the RAA. As a consequence, in CAF myocytes isoproterenol-mediated I to1 and I K1 inhibition and I Ks augmentation were significantly enhanced. Moreover, in SR myocytes isoproterenol lengthened whereas in CAF myocytes it further shortened APD 90 . 
Effects of isoproterenol on human atrial repolarizing currents
In SR myocytes isoproterenol inhibited I to1 in a concentrationdependent manner, an effect completely prevented by atenolol. Our preliminary results suggested that this b1-Adrenoceptormediated effect is due to the sequential stimulation of AC and PKA. There is a previous report showing that in SR myocytes I to1 was unaffected by 1 mM isoproterenol.
14 The reasons for this discrepancy are unknown; however, and besides the difference in the concentrations tested, we hypothesized that it could be due to the effects on membrane proteins of the enzymatic treatment used for myocyte dissociation.
We also demonstrated that b1-Adrenoceptors stimulation inhibited inward I K1 generated at potentials negative to the E K , whereas it did not modify the outward component generated at potentials positive to it. This fact limits the putative physiological relevance of the effect since atrial RMP is generally more depolarized than the E K . We further confirmed that I Kur is weakly sensitive to b1-Adrenoceptor stimulation 15 since I Kur was insensitive to isoproterenol concentrations ,10 nM. Finally, the results indicated that human I Ks is extremely sensitive to the increasing effects produced upon b1-Adrenoceptor stimulation since EC 50 values were 0.5 -1 nM. It could be argued, however, that isoproterenol increasing effects were only apparent when I Ks is generated by pulses of long unphysiological duration (4 s) (Figure 3 ), while they were not present on the sustained current generated at the end of 250 ms pulses (Supplementary material online, Figure S6 ), whose duration resembles better the atrial APD. This could raise a doubt about the physiological relevance of the data here presented, particularly considering that CAF APD 90 was 100 ms. However, it should be stressed that I Ks density, and thus its contribution to cardiac repolarization, markedly increases at increasing driving frequencies particularly following b-Adrenoceptor stimulation. 9, 16 Therefore, data obtained with pulses of similar duration to that of human AP applied at very low frequencies are less representative of the I Ks activated during APs driven at 1 Hz than those obtained with long pulses. To confirm this hypothesis, we ran a previously described mathematical model of I Ks
16
and compared steady-state I Ks amplitude reached in SR and CAF cells in the absence and presence of 1 nM isoproterenol (Supplementary material online, Figure S10 ). As can be observed, there was an increased activation of I Ks during repetitive stimulation with 150 ms pulses, which suggests that I Ks accumulated during brief atrial APs will contribute to AP repolarization. Effects of isoproterenol on I Kur , I Ks , I K1 , and I CaL on cardiac myocytes from different species have been attributed to the sequential activation of AC and PKA, 10, 13, 17, 18 and thus, signalling pathways
were not further studied here. In SR the effects produced by b1-adrenergic stimulation on these currents were similar in LAA and RAA myocytes. This could be explained because transcriptional levels of b1-Adrenoceptors, AC, and PDE did not exhibit differences between LAA and RAA. In CAF myocytes, the effects produced by isoproterenol on I to1 , I Ks , I K1 , and I CaL were significantly greater than those produced in SR myocytes and this enhancement was more marked in the LAA than in the RAA. Quantitative analysis of the b1-Adrenoceptor mRNA level suggested that CAF produces an up-regulation of b1-Adrenoceptors which was also greater in the LA than in the RA. Conversely, mRNA levels of those AC and PDE that critically determine the intensity of the b1-Adrenoceptor stimulation in cardiac myocytes 19 remained unchanged. Thus, our results suggest that CAF-induced enhancement of b1-Adrenoceptor-mediated effects on ionic channels could be mainly attributed to a CAF-induced up-regulation of atrial b1-Adrenoceptors. However, CAF-induced changes in other proteins/enzymes also involved in b1-Adrenoceptor stimulation cannot be ruled out.
Functional impact
An important goal of this study was to compare the functional impact of b1-Adrenoceptor stimulation on the characteristics of APs recorded in SR and CAF myocytes. In fact, this was the reason why we selected a low isoproterenol concentration (1 nM), i.e. in an attempt to reproduce as much as possible the physiological setting, in which natural catecholamines reach plasma concentrations of 0.4-1.6 nM. 20 We demonstrated that in SR myocytes isoproterenol mainly prolonged the APD 50 leaving RMP and AP amplitude unaffected. These results agree with previous reports 21 and can be interpreted in the light of isoproterenol effects on each individual current. Indeed, plateau duration is determined by I CaL amplitude whose depolarizing effects are counterbalanced by the repolarizing I to1 and I Kur . 5 Therefore, isoproterenol increasing effects on I CaL , together with its inhibiting effects on I to1 , can account for the APD 50 prolongation observed in SR cells. This hypothesis was confirmed by the results obtained when incorporating the experimentally observed effects of isoproterenol on a mathematical simulation of SR APs. Interestingly, in CAF myocytes, isoproterenol prolonged APD 20 , did not modify APD 50 , and shortened the APD 90 . This suggested that in CAF myocytes the role of I CaL in determining the height and duration of the plateau decreases so much that the I to1 inhibition produced by isoproterenol resulted in a prolongation of APD 20 . On the other hand, here we also confirmed that CAF markedly increases I Ks . 8 Furthermore, CAF markedly enhanced the isoproterenol-increasing effects of I Ks, which is mainly involved in terminal repolarization. 18, 22 The combination of these two CAF-induced changes could account for the APD 90 shortening produced by isoproterenol in CAF myocytes. To confirm this hypothesis, we ran the mathematical model of 'type 3' CAF-remodelled AP as described by Courtemanche et al. 12 However, we additionally included a 100% increase in I K1
and I Ks . The incorporation of the isoproterenol effects in currents recorded in CAF myocytes produced an APD 90 shortening of similar magnitude to that observed experimentally. However, this result did not discard that the decrease in I CaL density itself was responsible for the observed effects. Thus, to answer this question we ran the model of a CAF-remodelled AP in which the 100% I Ks increase was not included. Under these conditions, isoproterenol did not shorten but lengthened APD 90 . Therefore, the results of the mathematical model strongly suggest that the CAF-induced increase on I Ks is critical to account for the b1-Adrenoceptor-induced shortening of APD 90 in CAF myocytes. These are exciting results considering that the duration of terminal repolarization, which is actually shortened by CAF, is a major determinant of ARP and that it is generally accepted that shortening of ARP favours re-entry.
1,2 Importantly, the role of I Ks in determining the APD rises in prominence at increasing beating frequencies. On the other hand, CAF also produces an heterogeneous increase in sympathetic innervation 25 which, in turn, might heterogeneously increase b1-Adrenoceptor stimulation, thus favouring repolarization heterogeneities within the atria. Additionally, up-regulation of b1-Adrenoceptors in CAF myocytes would probably imply the enhancement of most of the b1-Adrenoceptor-mediated deleterious effects including oxidative stress and fibrosis. 10, 19, 26 Moreover, it probably also alters intracellular Ca 2+ concentration and handling which in turn exert pro-arrhythmic (i.e. promoting triggered focal activity), pro-apoptotic, and pro-necrotic effects.
Study limitations
All samples came from atrial appendages which could not be representative of the rest of the atria. Moreover, due to the limited availability of LA samples, effects of isoproterenol on AP were only assessed in RAA cells. However, since CAF increases I Ks density similarly in both atria 8 and isoproterenol more markedly increases I Ks in the LA than in the RA, it seems reasonable to assume that isoproterenol also shortens APD in the LA. Furthermore, atrial remodelling may be influenced by pharmacological treatment, gender, and/or underlying cardiac diseases of the patients. 1, 2 Patients with valvular and valvular combined with ischaemic heart disease or under betablocker therapy were equally distributed in both groups (Supplementary material online, Table S1 ). Moreover, multiple linear regression analysis confirmed that the only variable that influences the potentiation of the b1-Adrenoceptor effects is the presence of CAF (Supplementary material online, Table S5 ). Furthermore, all experiments were carried out at room temperature, APs were recorded in isolated myocytes under current clamp conditions, and b1-Adrenoceptors were stimulated using a synthetic catecholamine.
Conclusions
The present results demonstrate, for the first time, that CAF increases the effects of b1-Adrenoceptor stimulation on human repolarizing currents preferentially in the LA. In CAF cells, isoproterenol further shortens the APD 90 as a consequence of the CAF-induced up-regulation of b1-Adrenoceptors and derangements in ion channels. Therefore, it could be hypothesized that sympathetic stimulation further promotes re-entry, thus favouring AF maintenance.
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